Navigation Links
Astronauts Test Use of Nutritional Supplements in Space
Date:8/17/2009

HOUSTON, Aug. 17 /PRNewswire/ -- After nearly four years of joint research of Houston-based AmeriSciences and NASA / Johnson Space Center (JSC), a senior NASA medical officer has confirmed that two of the resulting nutritional supplement formulas were used and tested in space by the astronauts of mission STS-125 of May 11, 2009 and the mission STS-127 of July 15, 2009 and are now in use and testing aboard the International Space Station.

This marks a milestone in the advancement of a project between AmeriSciences and NASA/JSC to develop nutritional supplements for the astronauts to meet the needs of long-duration spaceflight as well as conditioning here on Earth. Commenced through a Space Act Agreement between AmeriSciences and NASA/JSC back in the fall of 2005, this joint research effort has now progressed to in-flight testing as well as clinical ground studies to determine safety and effectiveness of the resulting formulations.

"NASA/JSC has always had to push forward with new technologies to meet the extreme conditions of outer space ... nutritional supplementation is another one of those areas of technology in which NASA can make a significant contribution to society as a whole while promoting the health of the participants in their space program," comments Lou Gallardo, Chairman of AmeriSciences. "We are proud to be working closely with NASA/JSC on this project and combining all of our expertise to create the best products possible for the astronauts."

The years of preparation and research by experts from both AmeriSciences and NASA has led to the use and testing of antioxidant and multivitamin formulations aboard the Space Shuttle and International Space Station. The commencement of use and testing of these formulas on Space Shuttle mission STS-125 was important to said research as this mission to repair the Hubble Space Telescope presented extra physiological challenges. Prolonged Extra-Vehicular Activities (EVAs or "spacewalks") and the high-orbit location of the telescope exposed the astronauts to an increased risk of higher levels of radiation and other medical concerns.

"This is just the first step towards preparing for the rigors of long-duration space flight on the human body," explains Gallardo, "the good news is that the results from this research can impact everyone's health here on Earth."

AmeriSciences currently markets versions of the two formulas used on these missions. They are marketed as AmeriSciences Omega Max (an Omega 3 fatty acid supplement) and AmeriSciences Premium Multivitamin.

For more information on AmeriSciences' Omega Max and Premium Multivitamin, please visit www.amerisciences.com. For general information about Space Shuttle missions STS-125 and STS-127, please visit www.nasa.gov.

AmeriSciences, LP is a privately held company headquartered in Houston, Texas specializing in premium quality nutritional products. AmeriSciences' current domestic and international products are built on the philosophy of exceeding industry standards in quality, safety and effectiveness. AmeriSciences provides products in the areas of men's health, women's health, weight management, sports performance and preventative nutrition.

    Contact:
    Melissa Smith
    AmeriSciences, LP
    281-617-0100


'/>"/>
SOURCE AmeriSciences, LP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers call for new space headache category following astronauts survey
2. Astronauts on International Space Station lose alarming amounts of hipbone strength
3. Why do astronauts suffer from space sickness?
4. Space Radiation a Risk for Astronauts
5. Microscopic astronauts to go back in orbit
6. NASA Astronauts, Exercise Exhibit To Be At Houston Marathon Events
7. Exercise May Help Female Astronauts Stay Strong
8. Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination
9. The Organic Center Refutes Misleading Nutritional Claims Made by United Kingdoms Food Standards Agency (FSA) in Agency Report on Health Value of Organic Foods
10. NeoStem Signs Agreement for Ceres Living, Inc. to Market Innovative Nutritional Supplement Designed to Optimize Stem Cell Functions
11. Is There a Nutritional Upside to a Down Economy?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... TEXAS (PRWEB) , ... January ... ... Texas-based healthcare and clinical research networking-technology company founded by patient survivors, today ... innovative BlueCloud® business model, networking technologies and patient-inspired initiatives. , Like ...
(Date:1/24/2017)... ... 23, 2017 , ... United Nations Foundation President and CEO ... City Policy, also known as the Global Gag Rule, last enacted in 2001. ... non-governmental organizations from receiving any U.S. foreign assistance for family planning if they ...
(Date:1/24/2017)... , ... January 23, 2017 , ... ... of a new plugin that allows sleep centers to automatically connect and initialize ... (SDI)—is a thin client browser plugin is quickly installed on first use and ...
(Date:1/23/2017)... ... January 23, 2017 , ... Ultimate Medical ... Education Summit to be held March 23-25, 2017 in Tampa, and reminded educators ... , The keynote speakers include Dr. Michelle R. Weise, executive director of the ...
(Date:1/23/2017)... Grants Pass, OR (PRWEB) , ... January 23, 2017 , ... ... disease, took to the air to educate listeners about the benefits of making new ... in the U.S.,” Kleyne said, “it’s appropriate that we expect water infrastructure to become ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... The global peripheral I.V. catheter market accounted for $3,702.2 ... grow at a CAGR of 6.0% during 2016-2022. The ... in the global market between the two types in ... segment accounted for the highest share in the global ... catheter market is witnessing high growth rate, due to ...
(Date:1/24/2017)... CHICAGO , January 23, 2017 ... solutions for life sciences, announces agClinical 3.3, the latest ... release further enables life science organizations to confidently and ... monitoring and better manage the electronic trial master file ... ...
(Date:1/23/2017)... , Jan. 23, 2017  HOPE BIOSCIENCES announced ... to develop and commercialize nuc -gemcitabine™ (APTA-12/HOPE-888) ... Korean pharmaceutical company. nuc -Gemcitabine ... against surface nucleolin found on many cancer cells, ... ADCs (antibody drug conjugates) or SMDCs (small molecule ...
Breaking Medicine Technology: